N
Centralnervesystemet
Parkinsons sygdom
Antiparkinsonmidler
Levodopa kombineret med decarboxylasehæmmer
MAO-B-hæmmere
COMT-hæmmere
Levodopa, decarboxylasehæmmer og COMT-hæmmer i kombination
Dopaminagonister
Antikolinerge midler
Amantadin
Levodopa, decarboxylasehæmmer og COMT-hæmmer i kombination
N04BA
Revideret:
27.11.2024
Karen Østergaard
(Forfatter),
Dansk Neurologisk Selskab
Tove Henriksen
(Referent),
Dansk Selskab for Bevægeforstyrrelser
Indledning | Anvendelsesområder | Behandlingsvejledning | Revurdering af behandlingen | Præparatvalg | Doseringsforslag | Nedsat lever- og/eller nyrefunktion | Kontraindikationer | Forsigtighedsregler | Patientsikkerhed | Bivirkninger | Interaktioner | Graviditet | Amning | Forgiftning | Farmakodynamik | Farmakokinetik | Tilskud | Præparater | Referencer
Der henvises i øvrigt også til Levodopa kombineret med decarboxylasehæmmer og COMT-hæmmere for en oversigt over præparater med indholdsstofferne hver for sig.
For yderligere oplysninger om behandling af Parkinsons sygdom, se antiparkinsonmidler.
Præparater
| Indholdsstof | Navn og firma | Dispform og styrke | Pakning | Pris enh. | Pris DDD |
|---|---|---|---|---|---|
| Carbidopa Entacapon Levodopa |
Corbilta Orion Pharma
|
filmovertrukne tabletter 200 mg+50 mg+200 mg | 100 stk. (Nordic Prime) | 2,82 | 6,35 |
| Carbidopa Entacapon Levodopa |
Lecigon® Nordic Infucare
|
enteralgel 20+5+20 mg/ml | 7 x 47 ml | 23,55 | 529,96 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 50+12,5+200 mg | 100 stk. | 1,71 | 15,37 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 50+12,5+200 mg | 130 stk. | 3,37 | 30,29 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 100 stk. | 4,27 | 25,63 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 130 stk. | 9,12 | 54,74 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | ||
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | 3,00 | 13,49 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk | 3,46 | 12,44 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 130 stk. | 9,48 | 34,14 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk | 3,46 | 10,37 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 130 stk. | 4,51 | 13,53 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. | 2,81 | 6,32 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 130 stk. | 11,82 | 26,60 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 175+43,75+200 mg | 100 stk | 4,62 | 11,88 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Rivopharm" SanoSwiss
Udgået
15.09.2025
|
filmovertrukne tabletter 75+18,75+200 mg | 100 stk. | ||
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Rivopharm" SanoSwiss
Udgået
15.09.2025
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk. | ||
| Carbidopa Entacapon Levodopa |
Pentiro STADA Nordic
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | 2,74 | 12,35 |
| Carbidopa Entacapon Levodopa |
Pentiro STADA Nordic
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | 2,99 | 13,44 |
| Carbidopa Entacapon Levodopa |
Pentiro STADA Nordic
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk. | ||
| Carbidopa Entacapon Levodopa |
Pentiro STADA Nordic
|
filmovertrukne tabletter 150+37,5+200 mg | 130 stk. | 4,50 | 13,50 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 50+12,5+200 mg | 100 stk. | ||
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | ||
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. (Orifarm) | 2,80 | 12,58 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. (2care4) | 2,77 | 12,46 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk. | ||
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk. (Orifarm) | 2,51 | 7,53 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk. (Medartuum) | ||
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. (Orifarm) | ||
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. | ||
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. (Medartuum) | ||
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. (2care4) | 2,82 | 6,35 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 100 stk. (2care4) | 4,28 | 25,71 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk. (Paranova) | 3,26 | 11,74 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk. (Ebb Medical) | 3,71 | 13,37 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk.( 2care4) | 3,43 | 12,35 |
Referencer
1563. Stocchi F, Rascol O, Kieburtz K et al. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Ann Neurol. 2010; 68(1):18-27, https://pubmed.ncbi.nlm.nih.gov/20582993/ (Lokaliseret 10. december 2021)
4678. Stoessl AJ. Continuous dopaminergic therapy in Parkinson disease: time to stride back?. Ann Neurol. 2010; 68:3-5, https://www.ncbi.nlm.nih.gov/pubmed/20583222 (Lokaliseret 17. oktober 2023)
